Ubiquitination of the p53 Tumor Suppressor
10.1007/978-1-4899-1922-9_11
Crossref book-chapter
Springer US
Ubiquitin and the Biology of the Cell (297)
Bibliography

Huibregtse, J. M., Maki, C. G., & Howley, P. M. (1998). Ubiquitination of the p53 Tumor Suppressor. Ubiquitin and the Biology of the Cell, 323–343.

Authors 3
  1. Jon M. Huibregtse (first)
  2. Carl G. Maki (additional)
  3. Peter M. Howley (additional)
References 87 Referenced 3
  1. Barbosa, M. S., Lowy, D. R., and Schiller, J. T., 1989, Papillomavirus polypeptides E6 and E7 are zinc-binding proteins, J. Virol. 63:1404–1407. (10.1128/JVI.63.3.1404-1407.1989) / J. Virol. by MS Barbosa (1989)
  2. Bosch, F. X., Manos, M. M., Muñoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R., and Shah, K. V., 1995, Prevalence of human papillomavirus in cervical cancer: A worldwide perspective, J. Natl. Cancer Inst. 87:796–802. (10.1093/jnci/87.11.796) / J. Natl. Cancer Inst. by FX Bosch (1995)
  3. Butz, K., Shahabeddin, L., Geisen, C., Spitkovsky, D., Ullman, A., and Hoppe-Seyler, F., 1995, Functional p53 protein in human papillomavirus-positive cancer cells, Oncogene 10:927–936. / Oncogene by K Butz (1995)
  4. Chan, S.-Y., Delius, H., Halpern, A. L., and Bernard, H.-U., 1995, Analysis of genomic sequences of 95 papillomavirus types: Uniting typing, phylogeny, and taxonomy, J. Virol. 69:3074–3083. (10.1128/JVI.69.5.3074-3083.1995) / J. Virol. by S-Y Chan (1995)
  5. Chen, J. C., Reid, C. E., Band, V., and Androphy, E. J., 1995, Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein, Science 269:529–531. (10.1126/science.7624774) / Science by JC Chen (1995)
  6. Chen, P., Johnson, P., Sommer, T., Jentsch, S., and Hochstrasser, M., 1993, Multiple ubiquitin-conjugating enzymes participate in the in vivo degradation of the yeast MATα2 repressor, Cell 74:357–389. (10.1016/0092-8674(93)90426-Q) / Cell by P Chen (1993)
  7. Chowdary, D. R., Dermody, J. J., Jha, K. K., and Ozer, H. L., 1994, Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway, Mol. Cell. Biol. 14:1997–2003. (10.1128/MCB.14.3.1997) / Mol. Cell. Biol. by DR Chowdary (1994)
  8. Ciechanover, A., DiGiuseppe, J. A., Bercovich, B., Orlan, A., Richter, J. D., Schwartz, A. L., and Brodeur, G. M., 1991, Degradation of nuclear oncoproteins by the ubiquitin proteolysis system in vitro, Proc. Natl. Acad. Sci. USA 88:139–143. (10.1073/pnas.88.1.139) / Proc. Natl. Acad. Sci. USA by A Ciechanover (1991)
  9. Ciechanover, A., Shkedy, D., Oren, M., and Bercovich, B., 1994, Degradation of the tumor suppressor protein p53 by the ubiquitin-mediated proteolytic system requires a novel species of ubiquitin-carrier protein, E2, J. Biol. Chem. 269:9582–9589. (10.1016/S0021-9258(17)36921-1) / J. Biol. Chem. by A Ciechanover (1994)
  10. Crook, T., and Vousden, K. H., 1992, Properties of p53 mutations detected in primary and secondary cervical cancers suggest mechanisms of metastasis and involvement of environmental carcinogens, EMBO J. 11:3935–3940. (10.1002/j.1460-2075.1992.tb05487.x) / EMBO J. by T Crook (1992)
  11. Crook, T., Wrede, D., and Vousden, K. H., 1991, p53 point mutation in HPV negative human cervical carcinoma cell lines, Oncogene 6:873–875. / Oncogene by T Crook (1991)
  12. Crook, T., Ludwig, R. L., Marston, N. J., Willkomm, D., and Vousden, K. H., 1996, Sensitivity of p53 lysine mutants to ubiquitin-directed degradation targeted by human papillomavirus E6, Virology 217:285–292. (10.1006/viro.1996.0115) / Virology by T Crook (1996)
  13. Debbas, M., and White, E., 1993, Wild-type p53 mediates apoptosis by El A, which is inhibited by E1B, Genes Dev. 7:546–554. (10.1101/gad.7.4.546) / Genes Dev. by M Debbas (1993)
  14. DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J.-Y., Huang, C.-M., Lee, W.-H., Marsilio, E., Paucha, E., and Livingston, D. M., 1988, SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene, Cell 54:275–283. (10.1016/0092-8674(88)90559-4) / Cell by JA DeCaprio (1988)
  15. Demers, G. W., Foster, S. A., Halbert, C. L., and Galloway, D. A., 1994, Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7, Proc. Natl. Acad. Sci. USA 91:4382–4386. (10.1073/pnas.91.10.4382) / Proc. Natl. Acad. Sci. USA by GW Demers (1994)
  16. DeVilliers, E. M., 1989, Heterogeneity of the human papillomavirus group, J. Virol. 63:4898–4903. (10.1128/JVI.63.11.4898-4903.1989) / J. Virol. by EM DeVilliers (1989)
  17. Dohmen, R. J., Madura, K., Bartel, B., and Varshavsky, A., 1991, The N-end rule is mediated by the UBC2(RAD6) ubiquitin-conjugating enzyme, Proc. Natl. Acad. Sci. USA 88:7351–7355. (10.1073/pnas.88.16.7351) / Proc. Natl. Acad. Sci. USA by RJ Dohmen (1991)
  18. Dyson, N., Guida, P., Münger, K., and Harlow, E., 1992, Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins, J. Virol. 66:6893–6902. (10.1128/JVI.66.12.6893-6902.1992) / J. Virol. by N Dyson (1992)
  19. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B., 1993, WAF1, a potential mediator of p53 tumor suppression, Cell 75:817–825. (10.1016/0092-8674(93)90500-P) / Cell by WS El-Deiry (1993)
  20. Foster, S. A., Demers, G. W., Etscheid, B. G., and Galloway, D. A., 1994, The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest, J. Virol. 68:5698–5705. (10.1128/JVI.68.9.5698-5705.1994) / J. Virol. by SA Foster (1994)
  21. Friend, S., 1994, p53: A glimpse at the puppet behind the shadow play, Science 265:334–335. (10.1126/science.8023155) / Science by S Friend (1994)
  22. Funk, W. D., Pak, D. T., Karas, R. H., Wright, W. E., and Shay, J. W., 1992, A transcriptionally active DNA-binding site for human p53 protein complexes, Mol. Cell. Biol. 12:2866–2871. (10.1128/MCB.12.6.2866) / Mol. Cell. Biol. by WD Funk (1992)
  23. Girod, P. A., and Vierstra, R. D., 1993, A major ubiquitin conjugation system in wheat germ extracts involves a 15-kDa ubiquitin-conjugating enzyme (E2) homologous to the yeast UBC4/UBC5 gene products, J. Biol. Chem. 268:955–960. (10.1016/S0021-9258(18)54026-6) / J. Biol. Chem. by PA Girod (1993)
  24. Girod, P.-A., Carpenter, T. P., van Nocker, S., Sullivan, M. L., and Vierstra, R. D., 1993, Homologs of the essential ubiquitin conjugating enzymes UBC1,4, and 5 in yeast are encoded by a multigene family in Arabidopsis thaliana, Plant J. 3:545–552. (10.1046/j.1365-313X.1993.03040545.x) / Plant J. by P-A Girod (1993)
  25. Gronostajski, R. M., Goldberg, A. L., and Pardee, A. B., 1984, Energy requirement for degradation of tumor associated protein p53, Mol. Cell. Biol. 4:442–448. (10.1128/MCB.4.3.442) / Mol. Cell. Biol. by RM Gronostajski (1984)
  26. Gu, J., Ren, K., Dubner, R., and Iadarola, M. J., 1994, Cloning of a DNA binding protein that is a tyrosine kinase substrate and recognizes an upstream initiator-like sequence in the prodynorphin promoter, Mol. Brain Res. 24:77–88. (10.1016/0169-328X(94)90120-1) / Mol. Brain Res. by J Gu (1994)
  27. Han, J., Sabbatini, P., Perez, D., Rao, L., Modha, D., and White, E., 1996, The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein, Genes Dev. 10:461–477. (10.1101/gad.10.4.461) / Genes Dev. by J Han (1996)
  28. Hawley-Nelson, P., Vousden, K. H., Hubbert, N. L., Lowy, D. R., and Schiller, J. T., 1989, HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes, EMBO J. 8:3905–3910. (10.1002/j.1460-2075.1989.tb08570.x) / EMBO J. by P Hawley-Nelson (1989)
  29. Hubbert, N. L., Sedman, S.A., and Schiller, J. T., 1992, Human papillomavirus type 16 E6 increases the degradation rate of p53 in human keratinocytes J. Virol. 66:6237–6241. (10.1128/JVI.66.10.6237-6241.1992) / J. Virol. by NL Hubbert (1992)
  30. Huibregtse, J. M., Scheffner, M., and Howley, P. M., 1991, A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18, EMBO J. 10:4129–4135. (10.1002/j.1460-2075.1991.tb04990.x) / EMBO J. by JM Huibregtse (1991)
  31. Huibregtse, J. M., Scheffner, M., and Howley, P. M., 1993a, Cloning and expression of the cDNA for E6-AP., a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53, Mol. Cell. Biol. 13:775–784. (10.1128/MCB.13.2.775) / Mol. Cell. Biol. by JM Huibregtse (1993)
  32. Huibregtse, J. M., Scheffner, M., and Howley, P. M., 1993b, Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins, Mol. Cell. Biol. 13:4918–4927. (10.1128/MCB.13.8.4918) / Mol. Cell. Biol. by JM Huibregtse (1993)
  33. Huibregtse, J. M., Scheffner, M., Beaudenon, S., and Howley, P. M., 1995, A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase, Proc. Natl. Acad. Sci. USA 92:2563–2567. (10.1073/pnas.92.7.2563) / Proc. Natl. Acad. Sci. USA by JM Huibregtse (1995)
  34. Hupp, T., R., Meek, D. W., Midgley, C. A., and Lane, D. P., 1992, Regulation of the specific DNA binding function of p53, Cell 71:875–886. (10.1016/0092-8674(92)90562-Q) / Cell by TR Hupp (1992)
  35. Jensen, J. P., Bates, P. W., Yang, M., Vierstra, R. D., and Weissman, A. M., 1995, Identification of a family of closely related human ubiquitin conjugating enzymes, J. Biol. Chem. 270:30408–30413. (10.1074/jbc.270.51.30408) / J. Biol. Chem. by JP Jensen (1995)
  36. Johnson, E. S., Ma, P. C. M., Ota, I. M., and Varshavsky, A., 1995, A proteolytic pathway that recognizes ubiquitin as a degradation signal, J. Biol. Chem. 270:17442–17456. (10.1074/jbc.270.29.17442) / J. Biol. Chem. by ES Johnson (1995)
  37. Juven, T., Barak, Y., Zauberman, A., George, D. L., and Oren, M., 1993, Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene, Oncogene 8:3411–3416. / Oncogene by T Juven (1993)
  38. Kastan, M. B., Onyerkwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W., 1991, Participation of p53 protein in the cellular response to DNA damage, Cancer Res. 53:6304–6311. / Cancer Res. by MB Kastan (1991)
  39. Kern, S. E., Pietenpol, J. A., Thiagalingam, S., Seymour, A., Kinzler, K. W., and Vogelstein, B., 1992, Oncogenic forms of p53 inhibit p53-regulated gene expression, Science 256:827–830. (10.1126/science.1589764) / Science by SE Kern (1992)
  40. Kessis, T. D., Slebos, R. J., Nelson, W. G., Kastan, M. B., Plunkett, B. S., Han, S. M., Lorincz, A. T.
  41. Hedrick, L., and Cho, K. R., 1993, Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage, Proc. Natl. Acad. Sci. USA 90:3988–3992. (10.1073/pnas.90.9.3988) / Proc. Natl. Acad. Sci. USA by L Hedrick (1993)
  42. Kishino, T., Lalande, M., and Wagstaff, J., 1997, UBE3/E6-AP mutations cause Angelman syndrome, Nature Genet. 15:70–73. (10.1038/ng0197-70) / Nature Genet. by T Kishino (1997)
  43. Klingelhutz, A. J., Foster, S. A., and McDougall, J. K., 1996, Telomerase activation by the E6 gene product of human papillomavirus type 16, Nature 380:79–82. (10.1038/380079a0) / Nature by AJ Klingelhutz (1996)
  44. Ko, L. J., and Prives, C., 1996, p53: Puzzle and paradigm, Genes Dev. 10:1054–1072. (10.1101/gad.10.9.1054) / Genes Dev. by LJ Ko (1996)
  45. Kumar, S., Tomooka, Y., and Noda, M., 1992, Identification of a set of genes with developmentally down-regulated expression in the mouse brain, Biochem. Biophys. Res. Commun. 185:1155–1161. (10.1016/0006-291X(92)91747-E) / Biochem. Biophys. Res. Commun. by S Kumar (1992)
  46. Lane, D. P., 1992, p53, guardian of the genome, Nature 358:15–16. (10.1038/358015a0) / Nature by DP Lane (1992)
  47. Lane, D. P., and Crawford, L. V., 1979, T antigen is bound to a host protein in SV40-transformed cells, Nature 278:261–263. (10.1038/278261a0) / Nature by DP Lane (1979)
  48. Lechner, M. S., and Laimins, L. A., 1994, Inhibition of p53 DNA binding by human papillomavirus E6 proteins, J. Virol. 68:4262–4273. (10.1128/JVI.68.7.4262-4273.1994) / J. Virol. by MS Lechner (1994)
  49. Levine, A. J., Momand, J., and Finlay, C. A., 1991, The p53 tumour suppressor gene, Nature 351:453–456. (10.1038/351453a0) / Nature by AJ Levine (1991)
  50. Li, X., and Coffino, P., 1996, High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation, J. Virol. 70:509–516. / J. Virol. by X Li (1996)
  51. Linzer, D. I. H., and Levine, A. J., 1979, Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells, Cell 17:43–52. (10.1016/0092-8674(79)90293-9) / Cell by DIH Linzer (1979)
  52. Lowe, S. W., and Ruley, H. E., 1993, Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis, Genes Dev. 7:535–545. (10.1101/gad.7.4.535) / Genes Dev. by SW Lowe (1993)
  53. Maki, C. G., Huibregtse, J. M., and Howley, P. M., 1996, In vivo ubiquitination and proteasome-mediated degradation of p53, Cancer Res, 56:2649–2654. / Cancer Res by CG Maki (1996)
  54. Maltzman, W., and Czyzyk, L., 1984, UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells, Mol. Cell. Biol. 4:1689–1694. (10.1128/MCB.4.9.1689) / Mol. Cell. Biol. by W Maltzman (1984)
  55. Mansfield, E., Hersperger, E., Biggs, J., and Shearn, A., 1994, Genetic and molecular analysis of hyperplastic discs, a gene whose product is required for regulation of cell proliferation in Drosophila melanogaster imaginal discs and germ wells, Dev. Biol. 165:507–526. (10.1006/dbio.1994.1271) / Dev. Biol. by E Mansfield (1994)
  56. Martson, N. J., Crook, T., and Vousden, K. H., 1994, Interaction of p53 with MDM2 is independent of E6 and does not mediate wild type transformation suppressor function, Oncogene 9:2707–2716. / Oncogene by NJ Martson (1994)
  57. Matsuura, T., Sutcliffe, J. S., Fang, P., Galjaard, R.-J., Jiang, Y., Benton, C. S., Rommens, J. M., and Beaudet, A. L., 1997, De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome, Nature Genet. 15:74–77. (10.1038/ng0197-74) / Nature Genet. by T Matsuura (1997)
  58. Medcalf, E. A., and Milner, J., 1993, Targeting and degradation of p53 by E6 of human papillomavirus type 16 is preferential for the 1620+ p53 conformation, Oncogene 8:2847–2851. / Oncogene by EA Medcalf (1993)
  59. Mietz, J. A., Unger, T., Huibregtse, J. M., and Howley, P. M., 1992, The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein, EMBO J. 11:5013–5020. (10.1002/j.1460-2075.1992.tb05608.x) / EMBO J. by JA Mietz (1992)
  60. Molinari, M., and Milner, J., 1995, p53 in complex with DNA is resistant to ubiquitin-dependent proteolysis in the presence of HPV-16 E6, Oncogene 10:1849–1854. / Oncogene by M Molinari (1995)
  61. Müller, D., Rehbein, M., Baumeister, H., and Richter, D., 1992, Molecular characterization of a novel rat protein structurally related to poly(A) binding proteins and the 70K protein of the U1 small nuclear ribonuclear particle (snRNP), Nucleic Acids Res. 20:1471–1475. (10.1093/nar/20.7.1471) / Nucleic Acids Res. by D Müller (1992)
  62. Münger, K., Phelps, W. C., Bubb, V., Howley, P. M., and Schlegel, R., 1989, The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes, J. Virol. 63:4417–4421. (10.1128/JVI.63.10.4417-4421.1989) / J. Virol. by K Münger (1989)
  63. Nakao, M., Sutcliffe, J. S., Durtschi, B., Mutirangura, A., Ledbetter. D. H., and Beaudet, A., 1994, Imprinting analysis of three genes in the Prader-Willi/Angelman region: SNRNP., E6-associated protein, and PAR-2 (D15S225E), Hum. Mol. Genet. 3:309–315. (10.1093/hmg/3.2.309) / Hum. Mol. Genet. by M Nakao (1994)
  64. Nefsky, B., and Beach, D., 1996, Publ acts as an E6-AP-like protein ubiquitin ligase in the degradation of cdc25, EMBO J. 15:1301–1312. (10.1002/j.1460-2075.1996.tb00472.x) / EMBO J. by B Nefsky (1996)
  65. Nuber, U., Schwarz, S., Kaiser, P., Schneider, R., and Scheffner, M., 1996, Cloning of human ubiquitin-conjugating enzymes UbcH6 and UbcH7 (E2-F1) and characterization of their interaction with E6-AP and RSP5, J. Biol. Chem. 271:2795–2800. (10.1074/jbc.271.5.2795) / J. Biol. Chem. by U Nuber (1996)
  66. Pietenpol, J. A., Tokino, T., Thiagalingam, S., El-Deiry, W. S., Kinzler, K. W., and Vogelstein, B., 1994, Sequence-specific transcriptional activation is essential for growth suppression by p53, Proc. Natl. Acad. Sci. USA 91:1998–2002. (10.1073/pnas.91.6.1998) / Proc. Natl. Acad. Sci. USA by JA Pietenpol (1994)
  67. Rosa, J. L., Casaroli-Marano, R. P., Buckler, A. J., Vilaro, S., and Barbacid, M., 1996, p619, a giant protein related to the chromosome condensation regulator RCC1, stimulates guanine nucleotide exchange in ARF1 and Rab proteins, EMBO J. 15:4262–4273. (10.1002/j.1460-2075.1996.tb00801.x) / EMBO J. by JL Rosa (1996)
  68. Sarnow, P., Ho, Y. S., Williams, J., and Levine, A. J., 1982, Adenovirus Elb-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54kd cellular protein in transformed cells, Cell 28:387–394. (10.1016/0092-8674(82)90356-7) / Cell by P Sarnow (1982)
  69. Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., and Howley, P. M., 1990, The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53, Cell 63:1129–1136. (10.1016/0092-8674(90)90409-8) / Cell by M Scheffner (1990)
  70. Scheffner, M., Miinger, K., Byrne, J. C., and Howley, P. M., 1991, The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines, Proc. Natl. Acad. Sci. USA 88:5523–5527. (10.1073/pnas.88.13.5523) / Proc. Natl. Acad. Sci. USA by M Scheffner (1991)
  71. Scheffner, M., Miinger, K., Huibregtse, J. M., and Howley, P. M., 1992a, Targeted degradation of the retinoblastoma protein by human papillomavirus E7-E6 fusion proteins, EMBO J. 11:2425–2431. (10.1002/j.1460-2075.1992.tb05307.x) / EMBO J. by M Scheffner (1992)
  72. Scheffner, M., Takahashi, T., Huibregtse, J. M., Minna, J. D., and Howley, P. M., 1992b, Interaction of the human papillomavirus type 16 oncoprotein with wild-type and mutant p53 proteins, J. Virol. 66:5100–5105. (10.1128/JVI.66.8.5100-5105.1992) / J. Virol. by M Scheffner (1992)
  73. Scheffner, M., Huibregtse, J. M., Vierstra, R. D., and Howley, P. M., 1993, The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53, Cell 75:495–505. (10.1016/0092-8674(93)90384-3) / Cell by M Scheffner (1993)
  74. Scheffner, M., Huibregtse, J. M., and Howley, P. M., 1994, Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53, Proc. Natl. Acad. Sci. USA 91:8797–8801. (10.1073/pnas.91.19.8797) / Proc. Natl. Acad. Sci. USA by M Scheffner (1994)
  75. Scheffner, M., Nuber, U., and Huibregtse, J. M., 1995, Protein ubiquitination involving an E1-E2-E3 enzyme thioester cascade, Nature 373:81–83. (10.1038/373081a0) / Nature by M Scheffner (1995)
  76. Seufert, W., and Jentsch, S., 1990, Ubiquitin conjugating enzymes UBC4 and UBC5 mediate selective degradation of short-lived and abnormal proteins, EMBO J. 9:543–550. (10.1002/j.1460-2075.1990.tb08141.x) / EMBO J. by W Seufert (1990)
  77. Takenaka, I., Morin, F., Seizinger, B. R., and Kley, N., 1995, Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases, J. Biol. Chem. 270:5405–5411. (10.1074/jbc.270.10.5405) / J. Biol. Chem. by I Takenaka (1995)
  78. van den Heuvel, S. J., van Laar, T., The, I., and van der Eb, A. J., 1993, Large E1B proteins of adenovirus types 5 and 12 have different effects on p53 and distinct roles in cell transformation, J. Virol. 67:5226–5234. (10.1128/JVI.67.9.5226-5234.1993) / J. Virol. by SJ Heuvel van den (1993)
  79. Vogelstein, B., and Kinzler, K. W., 1992, p53 function and dysfunction, Cell 70:523–526. (10.1016/0092-8674(92)90421-8) / Cell by B Vogelstein (1992)
  80. von Knebel-Doeberitz, M., Oltersdorf, T., Schwarz, E., and Gissmann, L., 1988, Correlation to modify human papillomavirus early gene expression with altered growth properties in C4-I cervical carcinoma cells, Cancer Res. 48:3780–3785. / Cancer Res. by M Knebel-Doeberitz von (1988)
  81. von Knebel-Doeberitz, M., Bauknecht, T., Bartsch, D., and zur Hausen, H., 1991, Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells, Proc. Natl. Acad. Sci. USA 88:1411–1415. (10.1073/pnas.88.4.1411) / Proc. Natl. Acad. Sci. USA by M Knebel-Doeberitz von (1991)
  82. Werness, B. A., Levine, A. J., and Howley, P. M., 1990, Association of human papillomavirus types 16 and 18 E6 proteins with p53, Science 248:76–79. (10.1126/science.2157286) / Science by BA Werness (1990)
  83. White, E., 1994, p53, guardian of Rb, Nature 371:21–22. (10.1038/371021a0) / Nature by E White (1994)
  84. Whyte, P., Buchkovich, K. J., Horowitz, J. M., Friend, S. H., Raybuck, M., Weinberg, R. A., and Harlow, E., 1988, Association between an oncogene and an antioncogene: The adenovirus Ela proteins bind to the retinoblastoma gene product, Nature 334:124–129. (10.1038/334124a0) / Nature by P Whyte (1988)
  85. Yamamoto, Y., Huibregtse, J. M., and Howley, P. M., 1997, The human E6-AP gene (UBE3A) encodes three potential protein isoforms generated by differential splicing, Genomics, 41:263–266. (10.1006/geno.1997.4617) / Genomics by Y Yamamoto (1997)
  86. Yew, P. R., and Berk, A. J., 1992, Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein, Nature 357:82–85. (10.1038/357082a0) / Nature by PR Yew (1992)
  87. zur Hausen, H., and Schneider, A., 1987, The role of papillomaviruses in human anogenital cancers, in The Papovaviridae (N. Salzman and P. M. Howley, eds.), pp. 245–263, Plenum Press, New York. (10.1007/978-1-4757-0584-3_9) / The Papovaviridae by H Hausen zur (1987)
Dates
Type When
Created 12 years, 2 months ago (June 20, 2013, 8:57 p.m.)
Deposited 3 years, 6 months ago (Feb. 25, 2022, 2:11 p.m.)
Indexed 11 months, 3 weeks ago (Sept. 7, 2024, 2:23 p.m.)
Issued 27 years, 7 months ago (Jan. 1, 1998)
Published 27 years, 7 months ago (Jan. 1, 1998)
Published Print 27 years, 7 months ago (Jan. 1, 1998)
Funders 0

None

@inbook{Huibregtse_1998, title={Ubiquitination of the p53 Tumor Suppressor}, ISBN={9781489919229}, url={http://dx.doi.org/10.1007/978-1-4899-1922-9_11}, DOI={10.1007/978-1-4899-1922-9_11}, booktitle={Ubiquitin and the Biology of the Cell}, publisher={Springer US}, author={Huibregtse, Jon M. and Maki, Carl G. and Howley, Peter M.}, year={1998}, pages={323–343} }